Xponance’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Xponance's EXEL Position: Q2 2026 in Review
Xponance reduced its Exelixis (EXEL) stake by 30% in Q2 2026, selling an estimated $811K and leaving 38,890 shares worth $2.12M. The position accounts for 0.01% of the portfolio, ranked #573.
Xponance first reported a position in EXEL in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.5M in Q2 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Xponance held 38,890 shares of Exelixis worth $2.12M as of Q2 2026.
- Xponance sold 16,649 Exelixis shares in Q2 2026, an estimated $811K.
- Exelixis made up 0.01% of Xponance's portfolio in Q2 2026, its #573 holding.
- Xponance first reported a position in Exelixis in Q2 2020 and has held it in 25 quarters since.
- Xponance's Exelixis position peaked at $2.5M in Q2 2025.
- 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.